L. Terstappen

Oncology · 2004–2009

A researcher in the Science corpus: 6 papers; trusts 2 researchers and is trusted by 2 researchers here, as inferred from the citation graph.

Subfields

• Oncology — 22 citations into it; #1,260 of 1,698 by trust here, #296 by citations
• Cancer Research — 14 citations into it

Whom L. Terstappen trusts

Their strongest outbound trust, strongest first, inferred from their citations.

1. M. Miller (in Oncology)
2. G. Doyle (in Oncology)

Who trusts L. Terstappen

1. G. Doyle (in Oncology)
2. M. Miller (in Oncology)

Papers from L. Terstappen's perspective

Ordered by how strongly the researchers L. Terstappen trusts endorse each paper. Same corpus, a different order for every researcher.

1. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited (Nature Reviews. Cancer)
2. Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis. (Journal of Clinical Oncology)
3. Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System (Clinical Cancer Research)
4. Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall Survival (Clinical Cancer Research)
5. Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer (Clinical Cancer Research)
6. Circulating Tumor Cell Number as a Prognostic Marker in Progressive Castration-Resistant Prostate Cancer: Use in Clinical Practice and Clinical Trials (The Lancet Oncology)
7. Isolation of rare circulating tumour cells in cancer patients by microchip technology (Nature)
8. Circulating tumor cells (CTC) detection: clinical impact and future directions. (Cancer Letters)
9. Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. (Journal of Clinical Oncology)
10. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. (New England Journal of Medicine)

Their papers

• Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases (2004) — 2,448 citations
• Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer (2009) — 759 citations
• Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer (2008) — 1,983 citations
• Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. (2008) — 1,788 citations
• Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. (2005) — 1,126 citations
• Circulating tumor cells, disease progression, and survival in metastatic breast cancer. (2004) — 4,418 citations